- Home
- HRTX vs NPCT Comparison
HRTX vs NPCT Comparison
Compare HRTX & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- NPCT
- Stock Information
- Founded
- HRTX 1983
- NPCT 2020
- Country
- HRTX United States
- NPCT United States
- Employees
- HRTX N/A
- NPCT N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- NPCT Investment Managers
- Sector
- HRTX Health Care
- NPCT Finance
- Exchange
- HRTX Nasdaq
- NPCT Nasdaq
- Market Cap
- HRTX 325.0M
- NPCT 306.8M
- IPO Year
- HRTX 1987
- NPCT N/A
- Fundamental
- Price
- HRTX $1.98
- NPCT $10.77
- Analyst Decision
- HRTX Strong Buy
- NPCT
- Analyst Count
- HRTX 2
- NPCT 0
- Target Price
- HRTX $5.00
- NPCT N/A
- AVG Volume (30 Days)
- HRTX 1.1M
- NPCT 107.1K
- Earning Date
- HRTX 08-05-2025
- NPCT 01-01-0001
- Dividend Yield
- HRTX N/A
- NPCT 9.82%
- EPS Growth
- HRTX N/A
- NPCT N/A
- EPS
- HRTX N/A
- NPCT N/A
- Revenue
- HRTX $148,518,000.00
- NPCT N/A
- Revenue This Year
- HRTX $12.08
- NPCT N/A
- Revenue Next Year
- HRTX $12.57
- NPCT N/A
- P/E Ratio
- HRTX N/A
- NPCT N/A
- Revenue Growth
- HRTX 12.43
- NPCT N/A
- 52 Week Low
- HRTX $1.04
- NPCT $8.58
- 52 Week High
- HRTX $3.73
- NPCT $10.63
- Technical
- Relative Strength Index (RSI)
- HRTX 49.25
- NPCT 61.25
- Support Level
- HRTX $1.90
- NPCT $10.55
- Resistance Level
- HRTX $2.07
- NPCT $10.75
- Average True Range (ATR)
- HRTX 0.10
- NPCT 0.12
- MACD
- HRTX 0.00
- NPCT -0.01
- Stochastic Oscillator
- HRTX 32.81
- NPCT 56.28
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.